GSK "UGOLEK", Belgorod Oblast

Economic indicators

Net profit (RAS) of GSK UGOLEK made up 0 RUB over 2023 compared to net loss of 6.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 594.00 thousand RUB in 2022; cost of goods sold decreased ? times to 0.00 thousand RUB from 594.00 thousand RUB.

Net loss (RAS) of GSK UGOLEK increased 3.00 times to 6.00 thousand RUB from 2.00 thousand RUB over 2021, the company informed.

Revenue remained in the accounting period at the same level and made up 594.00 thousand RUB compared to 596.00 thousand RUB 596.00 thousand RUB; cost of goods sold remained at the same level amounting to 594.00 thousand RUB compared to 596.00 thousand RUB.

Net loss (RAS) of GSK UGOLEK dropped over 2021 by 33.33% to 2.00 thousand RUB from 3.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 10.17% to 596.00 thousand RUB from 541.00 thousand RUB over 2020; cost of goods sold grew by 10.17% to 596.00 thousand RUB from 541.00 thousand RUB.

Net loss (RAS) of GSK UGOLEK dropped over 2020 by 7.69% to 36.00 thousand RUB from 39.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 6.40% to 541.00 thousand RUB from 578.00 thousand RUB in 2019; cost of goods sold decreased by 8.15% to 541.00 thousand RUB from 589.00 thousand RUB; sales profit made up 0 compared to net loss of 9.00 thousand RUB.

Revenue increased in the accounting period by 8.42% to 528.00 thousand RUB from 487.00 thousand RUB over 2015; cost of goods sold grew by 8.42% to 528.00 thousand RUB from 487.00 thousand RUB.

Net profit (RAS) of GSK Ugolek made up 0 RUB over 2014 compared to net loss of 32.00 thousand RUB over 2013, the company informed.

Revenue increased in the accounting period by 37.05% to 577.00 thousand RUB from 421.00 thousand RUB over 2013; cost of goods sold grew by 27.37% to 577.00 thousand RUB from 453.00 thousand RUB; sales profit made up 0 compared to net loss of 32.00 thousand RUB.

Revenue decreased in the accounting period by 1.41% to 421.00 thousand RUB from 427.00 thousand RUB in 2012; cost of goods sold grew by 6.09% to 453.00 thousand RUB from 427.00 thousand RUB.

Net profit (RAS) of GSK Ugolek made up 0 RUB over 2012 compared to net loss of 10.00 thousand RUB over 2011, the company informed.

Cost of goods sold decreased by 12.86% to 427.00 thousand RUB from 490.00 thousand RUB; sales profit made up 0 compared to net loss of 10.00 thousand RUB.

Companies in the region

• ENTEGRA INZHINIRING
• AGIDEL'
• TOPLIVNAYA KOMPANIYA INTOP
• SIBSTROYKOMPLEKS
• KATYUSHA